MicroRNA-23 inhibits PRRSV replication by directly targeting PRRSV RNA and possibly by upregulating type I interferons  by Zhang, Qiong et al.
MicroRNA-23 inhibits PRRSV replication by directly targeting PRRSV
RNA and possibly by upregulating type I interferons
Qiong Zhang a,b,c, Xue-kun Guo a,b,c, Li Gao a,b,c, Chen Huang a,b,c, Ning Li a,d, Xiaojuan Jia e,
Wenjun Liu e, Wen-hai Feng a,b,c,n
a State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China
b Ministry of Agriculture Key Laboratory of Soil Microbiology, College of Biological Sciences, China Agricultural University, Beijing 100193, China
c Department of Microbiology and Immunology, College of Biological Sciences, China Agricultural University, Beijing 100193, China
d Department of Molecular Biology, College of Biological Sciences, China Agricultural University, Beijing 100193, China
e Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
a r t i c l e i n f o
Article history:
Received 18 September 2013
Returned to author for revisions
19 October 2013
Accepted 17 December 2013
Available online 4 January 2014
Keywords:
PRRSV
microRNAs
miR-23
miR-378
miR-505
IFNs
IRF
a b s t r a c t
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally
and play critical roles in intricate networks of host–pathogen interactions and innate immunity. Porcine
reproductive and respiratory syndrome (PRRS) is one of the most important diseases affecting swine
industry worldwide. Here, we demonstrated that miR-23, miR-378, and miR-505 were antiviral host
factors against PRRS virus (PRRSV). Over-expression of the three miRNAs inhibited PRRSV infection in a
dose-dependent manner, respectively. Blockage of the three endogenously expressed miRNAs signiﬁ-
cantly enhanced PRRSV replication. Different type 2 PRRSV strains harbored conserved miR-23, miR-378,
and miR-505 target sites (TSs) that were sufﬁcient to confer miRNA-mediated repression of PRRSV
replication. Interestingly, miR-23 was capable of inducing type I interferon expression during PRRSV
infection through IRF3/IRF7 activation, which might further lead to the inhibition of virus infection.
These results suggest that miR-23, miR-378, and miR-505, especially miR-23, may have the potential to
be used as antiviral therapy against PRRSV infection.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is one of
the most important diseases in swine industry worldwide, and has
been causing signiﬁcant economic losses since it was ﬁrst reported
in the United States and Canada in 1987 (Wensvoort et al., 1992).
Porcine reproductive and respiratory syndrome virus (PRRSV), the
etiological agent of the disease, is an enveloped, positive-sense,
and single-stranded RNA virus belonging to the Arteriviridae family
within the order Nidovirales (Cavanagh, 1997). PRRSV includes two
major genotypes, the European type (type 1) and the North
American type (type 2) (Allende et al., 1999). The PRRSV genome
is about 15.4 kb in length, containing at least two large replication-
related genes (ORF1a and ORF1b), and eight structural protein
genes (GP2a, GP2b, GP3, GP4, GP5a, GP5b, the matrix protein M,
and the nucleocapsid N protein) (Firth et al., 2011; Johnson et al.,
2011).
MicroRNAs (miRNAs) are small (23 nt) non-coding RNAs that
regulate gene expression post-transcriptionally through degrada-
tion of mRNAs or inhibition of translation (Bartel, 2009). The RNA-
induced silencing complex (Rani et al., 2011) is the core miRNA-
mediated silencing machinery, where miRNA serves as a guide
RNA to target mRNAs bearing the complementary sequence. The
complementarity between the miRNA ‘seed region’ (positions 2–8
from the 50 end) and the sequence of the mRNA target is
considered to be critical for the speciﬁcity of miRNA-target mRNA
interaction (Carthew and Sontheimer, 2009). Yet speciﬁcity of the
miRNA is also inﬂuenced by other factors such as the presence and
cooperation between multiple target sites (TSs), the spacing
between TSs, proximity to the stop codon, position within the
mRNA, AU composition, and the target mRNA secondary structure
(Bartel, 2009; Shukla et al., 2011).
Mounting evidence suggests a complicated interplay between
viruses and miRNAs. On the one hand, a virus can exploit the
miRNA system to facilitate its replication (Gottwein et al., 2007).
On the other hand, multiple miRNAs in hosts have been identiﬁed
as inhibitors of viral replications by directly targeting viral gen-
omes (Huang et al., 2007; Otsuka et al., 2007; Song et al., 2010;
Zheng et al., 2013) or inhibiting factors necessary for viral life
cycles (Ouda et al., 2011; Triboulet et al., 2007). Additionally, host
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Table 1
Target sites prediction of 12 candidate miRNAs and conservation analysis on 168 PRRSV strains of target sites.
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Fig. 1. miR-23, miR-505, and miR-378 inhibit PRRSV replication. PAMs were transfected with mimics of the indicated miRNAs or negative control miRNA mimics (NC) for
24 h at the concentration of 60 nM, and then infected with JXwn06 strain for 48 h at a multiplicity of infection (MOI) of 0.01. (A) Cells were ﬁxed for immunoﬂuorescent
analysis of PRRSV N protein. Three miRNAs (miR-23, miR-505, and miR-378) showing efﬁcient inhibitory abilities were presented. (B) Culture supernatants were
simultaneously collected for virus titer analysis on PAMs. IFN-α was incubated 24 h at 100 U/ml before PRRSV infection, which served as positive control. (C) Transfection of
miRNAs has no effect on cell viability. MTT assay was performed on PAMs transfected with mimics of the indicated miRNAs or NC for 72 h at the concentration of 60 nM. Data
were representative of three independent experiments (mean7SD). (D) Apoptosis could not be induced by transfection of miR-23 mimics into PAMs. TUNEL analysis of
apoptosis was performed in PAMs either left untreated or transfected with 60 nM miR-23 or NC mimics for 72 h. Then, apoptosis (green, TUNEL positive) was detected.
Statistical signiﬁcance in B and C was analyzed by one-way ANOVA followed by post hoc Dunnett0s multiple comparison. Signiﬁcance compared to NC and mock-baseline,
respectively: nPo0.05; nnPo0.01; nnnPo0.001. Statistical signiﬁcance in D was analyzed by t-test.
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Fig. 2. miR-23, miR-505, and miR-378 suppress both JXwn06 and CH-1a replication dose-dependently. PAMs and Marc-145 cells were transfected with miR-23, miR-505, or
miR-378 mimics at the indicated doses (2 nM, 10 nM, and 60 nM), and cells were then infected with JXwn06 or CH-1a PRRSV strains (MOI¼0.01) 24 h after transfection. Cells
were collected 48 h (JXwn06) or 36 h (CH-1a) later for qRT-PCR analysis of ORF7 expression (normalized to GAPDH) (A), and viral yields in the supernatants were also
quantiﬁed (B). (C) The levels of PRRSV protein GP5 were analyzed by Western blot. Expression of β-actin was shown as a loading control. Data were representative of three
independent experiments (mean7SD). Statistical signiﬁcance was analyzed by t-test; nPo0.05.
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miRNAs can positively modulate immune responses to generate a
less permissive environment for viral replications (Wang et al.,
2010a). Recently, more and more miRNAs have been reported to be
involved in the regulation of immune systems including cytokine
responses, as well as intracellular signaling pathways (Contreras
and Rao, 2012; Olivieri et al., 2013). Whether host immune-related
miRNAs could affect PRRSV infection has not been investigated.
The immune system initially recognizes virus infection and
evokes antiviral responses by producing type I interferons (IFNs),
which are essential for both innate and adaptive immunity.
Different ligands can bind to Toll-like receptors (TLRs) and RIG-
I-like receptors (RLRs) and recruit kinases that mediate the
activation of the transcription factors AP-1 (heterodimer of ATF2
and c-Jun), NF-κB, IRF3 and IRF7, which are all required for
initiating the production of IFN-α/β (Baccala et al., 2007). Type I
interferons can initiate the activation of JAK/STAT signaling to
induce hundreds of IFN-stimulated genes (ISGs), which play an
important role in antiviral activities (Katze et al., 2002). Lots of
miRNAs have been characterized in regulating IFN production
(Contreras and Rao, 2012; Zhang et al., 2012; Zhou et al., 2010)
and maintaining mRNA stability (Li et al., 2012; Witwer et al.,
2010), as well as in regulating IFN downstream signals to modulate
antiviral immunity (Papadopoulou et al., 2012; Yoshikawa et al.,
2012). Most of them are identiﬁed to down-regulate the produc-
tion of IFNs (Alam and O’Neill, 2011), whereas few miRNAs
suggesting a positive role in induction of type I IFNs have been
reported.
Our previous study identiﬁed that mir-181 could suppress
PRRSV infection both in vitro and in vivo by directly targeting
PRRSV genome and down-regulating CD163, a vital receptor of
PRRSV (Gao et al., 2013; Guo et al., 2013). In order to ﬁnd more
potent PRRSV inhibitors, we screened potential miRNAs against
PRRSV infection through ectopic expression of 12 candidate
miRNAs and demonstrated that miR-23, miR-505, and miR-378
effectively suppressed PRRSV replication by directly targeting viral
RNAs. Moreover, miR-23 increased the expression of type I inter-
ferons during PRRSV infection by enhancing IRF3/IRF7 signaling,
which might further inhibit PRRSV replication. Our study here
deﬁned three host miRNAs antagonizing PRRSV, suggesting that
miR-23, miR-378, and miR-505, in particular miR-23, could be
used as antiviral therapy against PRRSV infection.
Results
miR-23, miR-378, and miR-505 inhibit PRRSV replication
Through miRNA target site (TS) prediction and conservation
analysis on genomic RNAs of 168 type 2 PRRSV strains (Table 1)
using RegRNA (Huang et al., 2006) or ViTa (Hsu et al., 2007) as
described before (Guo et al., 2013), we selected 12 miRNAs
including miR-23, miR-505, miR-378, mir-106, mir-128, mir-107,
mir-34, mir-146, mir-15, mir-16, mir-223, and mir-101 as candi-
date miRNAs for PRRSV inhibition analysis as their target sites
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Fig. 3. Inhibition of endogenous miR-23, miR-378, or miR-505 enhances PRRSV infection. (A, B, and C) PAMs were transfected with inhibitors of the three indicated miRNAs
or negative control miRNA (NC-inhib) for 24 h, and then infected with JXwn06 (MOI¼0.01). Thirty-six hour later, cells were ﬁxed for detection of PRRSV N protein by
immunoﬂuorescent staining (A), or harvested for the analysis of ORF7 expression using qRT-PCR, normalized to GAPDH (B). Culture supernatants were collected for virus
titer analysis (C). (D) qRT-PCR analysis of expression of endogenous miRNAs in PAMs. U6 was used as a control. CT, cycle threshold. Data were representative of three
independent experiments (mean7SD). Statistical signiﬁcance was analyzed by t-test; nPo0.05.
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were well conserved in type 2 PRRSV strains (Table 1). Of them,
the target sites of miR-23, miR-378, and miR-505 were highly
conserved (98.13%, 96.84%, and 95.00%, respectively) in type
2 PRRSV strains.
To examine whether these miRNAs can inhibit PRRSV, we
transfected each of the 12 miRNAs mimics into PAMs and tested
their effects on PRRSV replication. Our results showed that among
the 12 miRNA candidates, miR-23, miR-505, and miR-378 signiﬁ-
cantly impaired JXwn06 strain replication, reducing the virus
yields about 10, 10, and 5 folds lower relative to NC, respectively
(Fig. 1A and B). To rule out the possibility that transfection of
miRNA mimics could affect PAM viability to affect PRRSV infection,
MTT assay was performed after transfection of each of the 12
miRNAs mimics into PAMs. Our results showed that transfection of
the mimics had no effects on cell viability (Fig. 1C). A previous
study had suggested a role of the miR23a27a24-2 cluster in
inducing apoptosis (Chhabra et al., 2009). In order to clarify
whether miR-23 alone could induce apoptosis to affect the
replication of PRRSV, we performed a TUNEL assay after transfec-
tion of miR-23 mimics. Our results showed that over-expression of
miR-23 did not induce signiﬁcant apoptosis compared with NC
(Fig. 1D).
To further conﬁrm these results, we transfected mir-23, mir-
505, or mir-378 mimics at different doses into PAMs, and our
results showed that both mRNA levels of ORF7 and virus titers
were signiﬁcantly decreased in a dose-dependent manner (Fig. 2A
and B). Transfection of miR-23, miR-505, or miR-378 mimics at the
concentration of 60 nM could induce a 94%, 84%, and 80% decrease
of the PRRSV (JXwn06) ORF7 gene expression relative to NC in
PAMs, respectively (Fig. 2A), resulting in a signiﬁcant suppression
of infectious viral particle production (30-, 10-, and 5-fold
decrease, respectively) (Fig. 2B). The inhibitory effect was also
conﬁrmed by Western blot and the level of PRRSV GP5 was
reduced dose-dependently (Fig. 2C). Notably, the inhibitory prop-
erty of the three miRNAs was not restricted to JXwn06 strain, as a
similar suppression was observed on traditional PRRSV strain
CH-1a (Fig. 2A and B). We showed that when the cells were
transfected with miRNA mimics at a concentration of 60 nM, the
viability of PAMs was not affected. Thus, the dose (60 nM) was
used in the following experiment.
To further verify whether these three miRNAs target PRRSV
RNA and serve as direct antiviral factors, we infected PAMs with
PPRSV following the transfection of the corresponding miRNA
inhibitors and examined their effects on PRRSV replication.
As expected, blockage of the endogenously expressed host miR-
23, miR-505, or miR-378 signiﬁcantly enhanced PRRSV infection
compared to NC (Fig. 3A, B, and C), and the increase of viral yields
was about 5, 2, and 3 folds for miR-23, miR-505, and miR-378,
respectively (Fig. 3C). Among the three miRNAs, inhibition of miR-
23 had the most effective effect, which might be due to its highest
expression level in PAMs (Fig. 3D). Taken together, these data
suggested that among the 12 candidate miRNAs, miR-23, miR-378,
and miR-505 have the potential to inhibit PRRSV infection.
miR-23, miR-505, and miR-378 suppress PRRSV infection through
directly binding to PRRSV genomic and subgenomic RNAs
To investigate whether the reduced viral yields are due to the
direct targeting by these three miRNAs, we constructed ﬁreﬂy
luciferase reporter pGL3-30UTR-WT containing the predicted tar-
get site in the 30 UTR, and another construct pGL3-30UTR-Mut with
mutations in the seed region (Fig. 4A) (Since our data in Fig. 2
suggested that miR-23 was the most effective one of the three
miRNAs in PRRSV inhibition, we here used miR-23 as an example).
In the presence of miR-23, the luciferase activity of 30UTR-WT was
signiﬁcantly impaired to 33% relative to NC, which was rescued by
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Fig. 4. miR-23, miR-378, and miR-505 directly target PRRSV genomic RNA and subgenomic RNAs. (A, B, and C) miR-23 directly targets PRRSV genomic RNA. (A) Diagram of
the predicted target site for miR-23 in PRRSV genomic RNA. Seed sequences of miR-23 were underlined and mutated as indicated by the arrow. (B and C) Marc-145 cells were
infected with or without CH-1a at an MOI of 0.1 for 2 h, then co-transfected with wt or mutant luciferase reporter vectors, pRL-TK and miR-23 mimics or inhibitor (B) or with
different concentrations of miR-23 mimics (C). Cells in (B) and (C) were lysed 30 h post-transfection for dual-luciferase assay. (D, E, and F) miR-23, miR-378, and miR-505
physically bind to viral genomic and subgenomic RNAs in the RISC. qRT-PCR analysis of the relative expression of subgenomic mRNAs (sgRNAs), genomic RNA (gRNA), and
the indicated miRNAs in the total RNA extracted from RISC-IP samples from PAMs transfected with miR-23 (D), miR-505 (E) or miR-378 (F) mimics subsequently infected
with PRRSV JXwn06 at an MOI of 0.01, normalized to GAPDH. Data were representative of three independent experiments (mean7SD). Statistical signiﬁcance was analyzed
by t-test; nPo0.05; nnPo0.01; nnnPo0.001.
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mutating the six seed nucleotides of TS (30UTR-Mut), or by CH-1a
infection, in which virus RNAs might act as a sponge to attract free
miR-23 (Fig. 4B). The endogenous miR-23 also played a role in
inhibition, as blockage of miR-23 expression showed a 1.5-fold
increase in luciferase activity of 30UTR-WT (Fig. 4B). Over-expression
of miR-23 remarkably inhibited the luciferase activity of the 30UTR-
WT in a dose-dependent manner, with a highest inhibition percen-
tage of 66% at 60 nM, while luciferase activity of 30UTR-Mut was not
affected (Fig. 4C). These results conﬁrmed that the PRRSV genomic
RNA harbored functional miR-23TS that was sufﬁcient to confer miR-
23-mediated repression of PRRSV infection.
For PRRSV, its transcription strategy involves the synthesis of a
full-length genomic RNA and at least 6 nested subgenomic RNAs,
which share partial common sequences. To test whether miR-23,
miR-378, or miR-505 physically binds to the genomic and sub-
genomic RNAs (sg) to mediate the degradation of PRRSV RNAs, we
performed the RISC-IP assay. miR-23 has a binding site on PRRSV
ORF3 and might bind to genomic RNA and subgenomic RNA 2
(sg2). As expected, when miR-23 was over-expressed during
PRRSV infection, we detected a 16-fold enrichment of miR-23
and 7-fold enrichment of viral genomic RNA on RISC compared
to the IgG isotype control (Fig. 4D). However, the enrichment of
sg2 on RISC was not signiﬁcant, which might be due to other
factors that inﬂuence the speciﬁcity of the miR-23. In the case of
miR-505, it has TSs in ORF3 and ORF5, and three subgenomic RNAs
(sg2, sg3, and sg4) were enriched 2 to 4 folds on RISC along with
an over 10-fold enrichment of miR-505 (Fig. 4E). Over-expression
of miR-378 increased its own load on RISC about 7-fold and
enriched all viral RNAs 2 to 5 folds except for sg7 (Fig. 4F). Taken
together, these data demonstrated that miR-23, miR-378, and miR-
505 suppressed PRRSV replication by directly targeting its geno-
mic and subgenomic RNAs.
miR-23 increases type I interferon expression during PRRSV infection.
miR-23 showed better inhibitory effects on PRRSV replication
while its TS was not superior to the TS of miR-505 or miR-378,
implicating that other mechanismmight exist for miR-23 to suppress
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PRRSV replication. Interestingly, we found that over-expression of
miR-23 rendered the cells more competent in IFN-α and IFN-β
expression during both JXwn06 (3-fold higher) and CH-1a (2-
fold higher) infection when compared with NC (Fig. 5A and C).
Moreover, the IFN-stimulated genes MX1 and ISG15 were also
signiﬁcantly up-regulated (Fig. 5B and C). However, over-expression
of miR-505 or miR-378 did not increase type I IFN expression
(Fig. 5A). To rule out the possibility that miRNAs themselves could
serve as ligands for TLRs and activate IFNs (Fabbri et al., 2012;
Lehmann et al., 2012), we delivered miRNA mimics into PAMs
without PRRSV infection and quantitative real-time PCR was per-
formed to detect IFNs expression. Our results showed that miR-23
did not mediate the activation of IFNs in the absence of PRRSV
infection (Fig. 5A).
miR-23 increases the expression of type I interferons by the activation
of IRF3/IRF7 during PRRSV infection
To gain insight into the underlying mechanisms of IFN induc-
tion by miR-23 during PRRSV infection, inhibitors of AP-1
(SB203580), NF-κB (BAY11-7082), IRF3 and IRF7 (BX-795) were
applied. Quantitative PCR analysis of IFN-α/β expression showed
that the ability of miR-23 to induce type I interferons was severely
compromised when pretreated with IRF3/IRF7 inhibitor (Fig. 6A
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Fig. 6. miR-23 increases type I interferon expression through IRF3/IRF7 activation during PRRSV infection. (A, B and C) IRF3/IRF7 inhibitor impaired the induction of type I
IFNs during PRRSV infection. Transfection of miR-23 mimics or NC in PAMs was performed prior to the treatment of the indicated inhibitors or DMSO, followed by PRRSV
JXwn06 infection for 48 h (MOI¼0.01). Cells were then harvested for quantifying the expression of type I interferon genes IFN-β (A) and IFN-α (B), and ORF7 (C) using qRT-
PCR, normalized to GAPDH. The data were represented as fold changes of the indicated genes after over-expression of miR-23 (NC was set up as 1 and not shown in the
ﬁgure). Statistical signiﬁcance was analyzed by one-way ANOVA followed by post hoc Dunnett0s multiple comparison. Signiﬁcance compared to DMSO-baseline: nPo0.05.
(D, E, F, and G) miR-23 increases activation of IRF3 during PRRSV infection. Either miR-23 or NC mimics and pRL-TK were co-transfected with IRF3 (D), ISRE (E), or NF-κB
(F) luciferase reporters into Marc-145 cells. Cells were then either infected with CH-1a (MOI¼0.01) 6 h after transfection, or transfected with 1 μg poly(I:C) 24 h post
trasfection, or left untreated (mock). All cells were harvested 36 h post-transfection for dual-luciferase assay. (G) Western blot analysis of phospho-IRF3 or IRF3 in PAMs
transfected with miR-23 mimics followed by infection with JXwn06 (MOI¼0.01) for 48 h. β-actin was shown as a loading control. (H) miR-23 plays no role in IFN down-
stream pathway. Luciferase activity in lysates of CRL-2843 cells co-transfected with ISRE luciferase reporter, pRL-TK and miRNA mimics for 6 h and incubated with or without
10 U/ml IFN-α for 24 h. The data were represented as fold increase of ISRE. Data were representative of three independent experiments (mean7SD). Statistical signiﬁcance
was analyzed by t-test; nPo0.05; ns, not signiﬁcant.
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and B), suggesting that miR-23 mediates activation of type I IFNs
during PRRSV infection through IRF3/IRF7 pathway. Importantly,
interrupting the induced production of IFNs using IRF3/IRF7
inhibitor impaired the ability of miR-23 to inhibit PRRSV infection
(from 20-fold reduction to 3-fold reduction) (Fig. 6C), suggesting
that miR-23-induced IFNs might further inhibit PRRSV infection.
To verify whether the IRF signals were up-regulated by miR-23, we
made a reporter construct containing PRDIII/I regulatory element
to monitor IRF activities. IRF activity was signiﬁcantly increased to
2.9 folds in the presence of miR-23 when infected with CH-1a
(Fig. 6D). We also used a reporter construct containing interferon-
sensitive responsive element (ISRE) to monitor the downstream
signals of IFNs. As expected, the ISRE response was also enhanced
2.9 folds by miR-23 during CH-1a infection (Fig. 6E). Interestingly,
upon transfection of poly(I:C), a RIG-I-like receptors (RLRs) ligand
into Marc-145 cells, the activity of IRFs and the response of ISRE
were also increased about 2 folds by miR-23 (Fig. 6D and E),
suggesting that miR-23 has the ability to induce IFN production in
RLRs-mediated pathway. NF-κB did not participate in this path-
way. Thus, we set up NF-κB reporter as a negative control. As
expected, the activity of NF-κB was not altered by miR-23 (Fig. 6F).
To further conﬁrm the above results, we performed Western blot
to detect the activated IRF3 (phospho-IRF3) signals. Consistent
with our expectation, IRF3 activation was increased by miR-23
during PRRSV infection (Fig. 6G).
To investigate whether miR-23 could act on the IFN down-
stream pathway, we applied our experiments on CRL-2843 cells,
which are derived from porcine alveolar macrophage and can
respond well to porcine IFNs. We transfected CRL-2843 cells with
ISRE-reporter vector and miR-23 or miR-155 mimics (as a positive
control), and 6 h later, cells were mock treated or incubated with
IFN-α. The induction folds of ISRE stimulated by IFN-α were
calculated, which could represent the activation state of JAK/STAT
signals. Using this assay, we conﬁrmed that miR-23 did not
signiﬁcantly augment IFN-α-induced ISRE activity, suggesting that
miR-23 was not involved in IFN-α downstream pathway (Fig. 6H).
A previously study has shown that miR-155 was able to increase
the JAK/STAT signals by inhibiting SOCS1 (Wang et al., 2010a). And
as expected, miR-155 induced a more robust activation of JAK/
STAT signals compared to NC (1.7 fold higher) (Fig. 6H).
Collectively, we showed here that IRF3/IRF7 played a critical
role in miR-23-mediated induction of IFNs during PRRSV infection.
PRRSV infection does not induce the production of miR-23 and
miR-505, but suppresses the poly(I:C)-induced miR-23 and
miR-505 expression
To assess whether PRRSV inﬂuence the expression of miR-23,
miR-378, and miR-505 to facilitate its infection, a time course
analysis upon PRRSV infection was performed. Our results showed
that miR-378 was induced to about 2- fold higher at 10 h post
infection by both JXwn06 and CH-1a, while miR-23 and miR-505
remained stable (Fig. 7A and B). We then asked whether the three
miRNAs could be regulated in antiviral innate immunity against
RNA virus. We found that upon poly(I:C) incubation, which mimics
virus dsRNA stimulation, miR-23 and miR-505 were induced about
1.6-, and 2.5- folds at 24 h, respectively, and miR-378 was
increased about 2.1 folds at 10 h (Fig. 7C). Interestingly, our results
showed that PRRSV suppressed poly(I:C)-induced miR-23 and
miR-505 expressions at 24 h (Fig. 7D), which might be a strategy
for PRRSV to evade the RNA-mediated immune response induced
in TLR3 pathway.
Discussion
miRNAs are emerging as active and versatile regulators of
immune response and intricate networks of host-pathogen inter-
actions. Herein, we identiﬁed miR-23, miR-378, and miR-505 as
important inhibitors of the PRRSV replication by directly targeting
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PRRSV genomic and subgenomic RNAs. Moreover, mir-23 was also
shown to increase type I IFN expression and possibly generate a
less permissive environment for PRRSV replication.
Multiple lines of evidence have conﬁrmed that miRNAs can
modulate RNA-mediated host defenses against viral infection
through two mechanisms. First, miRNAs can serve a direct anti-
viral function through viral RNA binding. As for the primate foamy
virus PFV) (Lecellier et al., 2005), host miR-32 targets the viral
genome to efﬁciently restrain viral replication. Five interferon
(IFN)-induced miRNAs (mir-196, mir-296, mir-351, mir-431 and
mir-448) are shown to target the HCV genome and can inhibit HCV
replication (Pedersen et al., 2007). Second, miRNAs can indirectly
modulate host factors to provide a less permissive environment for
virus replication. For example, the miRNA cluster mir-17/92 was
found to be a negative regulator of HIV through inhibiting cellular
factor PCAF, which is important for efﬁcient HIV replication
(Triboulet et al., 2007). Similar to these results, we show here that
miR-23 inhibits PRRSV replication by directly targeting PRRSV
RNAs and that it may also inhibit PRRSV replication indirectly by
up-regulating type I interferons.
We showed that miR-23, miR-378, and miR-505 were antiviral
host factors against PRRSV (Fig. 1), and the three miRNAs could
signiﬁcantly reduce the replication of both JXwn06 and CH-1a
strains (Fig. 2). From miRNA target site prediction and conserva-
tion analysis (Table 1), we showed that the target sites of miR-23,
miR-505, and miR-378 were highly conserved among type 2 PRRSV
isolates. Moreover, blockage of endogenous miR-23, miR-378, and
miR-505 signiﬁcantly increased PRRSV infection (Fig. 3). Our data
suggested that miR-23, miR-378, and miR-505 may play a role in
the cellular responses to PRRSV infection.
PRRSV synthesizes a full-length genomic RNA and at least 6 nested
subgenomic RNAs, which share partial common sequences. Thus, we
proposed that besides genomic RNA, an miRNA might target other
corresponding subgenomic RNAs containing its TSs, which might
imply a more robust RNA-mediated defense against PPRSV as
sequence-speciﬁc binding sites increase. The results of RISC-IP sup-
ported our expectation (Fig. 4). We showed that almost all subge-
nomic RNAs harboring TSs were enriched in RISC along with
corresponding miRNAs. Therefore, our data demonstrated that miR-
23, miR-378, and miR-505 were novel antiviral host factors against
PRRSV by directly binding to the genomic or subgenomic RNAs.
In addition, we demonstrated that miR-23 induced type I IFN
expression through activation of IRF3/IRF7 (Figs. 5 and 6), whichmight
further inhibit PRRSV infection. To our knowledge, this is the ﬁrst
Table 2
Sequences of mimics and inhibitors of 12 miRNAs used in screening for anti-PRRSV miRNAs.
miRNAs Mimics sequence (50-30) Inhibitor sequence (50-30)
miR-23 AUCACAUUGCCAGGGAUUUCC GGAAAUCCCUGGCAAUGUGAU
miR-505 UCAACACUUGCUGGUUUCCUCU AGAGGAAACCAGCAAGUGUUGA
miR-378 ACUGGACUUGGAGUCAGAAGGC GCCUUCUGACUCCAAGUCCAGU
miR-106 AAAAGUGCUUACAGUGCAGGUAGC
miR-128 UCACAGUGAACCGGUCUCUUU
miR-107 AGCAGCAUUGUACAGGGCUAUCA
miR-34 UGGCAGUGUCUUAGCUGGUUGU
miR-146 UGAGAACUGAAUUCCAUAGGC
miR-15 UAGCAGCACAUAAUGGUUUGU
miR-16 UAGCAGCACGUAAAUAUUGGCG
miR-223 UGUCAGUUUGUCAAAUACC
miR-101 UACAGUACUGUGAUAACUGAA
Table 3
Primers and sequences used in RT-PCR and cloning.
Primers Sequence (50-30)
U6-F CTCGCTTCGGCAGCACA
U6-R AACGCTTCACGAATTTGCGT
ORF7-F AATAACAACGGCAAGCAGCA
ORF7-R GCACAGTATGATGCGTCGGC
GAPDH-F CCTTCCGTGTCCCTACTGCCAAC
GAPDH-R GACGCCTGCTTCACCACCTTCT
MX1-F CACAGAACTGCCAAGTCCAA
MX1-R GCAGTACACGATCTGCTCCA
ISG15-F GGTGCAAAGCTTCAGAGACC
ISG15-R GTCAGCCAGACCTCATAGGC
IFN-beta-F AGCACTGGCTGGAATGAAAC
IFN-beta-R TCCAGGATTGTCTCCAGGTC
IFN-alpha-F CTGCTGCCTGGAATGAGAGCC
IFN-alpha-R TGACACAGGCTTCCAGGTCCC
miR-23-F CGATCACATTGCCAGGGATTTCC
miR-378-F ACTGGACTTGGAGTCAGAAGGC
miR-505-F GCTCAACACTTGCTGGTTTCCTCT
Uni-miR-R primer GCGAGCACAGAATTAATACGACTCAC
30UTRwt-F GACTCTAGAATGAAATGGGGTCTATGCA
30UTRwt-R GACTCTAGAGTGTTGGTAGTAGGTCTG
30UTRmut-F CGGCCCAGTTCCATCCCGAGATATTTGGGATAGGGTACATACGTC
30UTRmut-R TGGTGCTTGATGTCAACATAAACTTGACGTATGTACCCTATCCCA
NF-κB responding element GTGGGAAATTCCGTGGGAAATTCCGTGGGAAATTCCGTGGGAAATTCC
ISRE responding element TCGAGAAACTGAAACTGAAACTGAAACTGAAACTGAAACTGAAACTGAAACTGAAACTGAAACT
IRFs responding element (PRDIII/I) TCGAGAAAACTGAAAGGGAGAACTGAAAGTGAAAACTGAAAGGGAGAACTGAAAGTGAAAACTGAAAGGGAGAACTGAAAGTG
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report about a miRNA-mediated activation of type I IFNs during viral
infection. Various kinds of strategies are taken by viruses to inhibit IFN
system. PRRSV exhibits signiﬁcant inhibition of type I IFN production
in both virus-infected cells and pigs by encoding IFN antagonists,
which include at least three non-structural proteins (Nsp1, Nsp2, and
Nsp11) and a structural protein (N protein) (Sun et al., 2012). The
induction of IFNs by miR-23 was not due to the low expressed IFN
antagonists, because in the case of miR-505, it was unable to induce
IFNs, even though they both exhibited comparable inhibition of PRRSV
(Fig. 5A). But the possibility that miR-23 interfered with certain PRRSV
proteins that may disturb IRF3/IRF7 activation could not be excluded.
To investigate the exact target factors of miR-23, we tested some host
candidates predicted to be targeted by miR-23, which have been
shown to negatively regulate IRF3/IRF7, including A20 (Parvatiyar
et al., 2010) and TAX1BP1 (Parvatiyar et al., 2010; Verstrepen et al.,
2011). However, RISC-IP results showed that they were not authentic
targets of miR-23 (data not shown). Over one thousand conserved
target mRNAs of miR-23 were predicted by Targetscan, including a
large scale of un-characterized proteins, among which might exist one
or more miR-23 target(s) involved in negative regulation of IRF3/IRF7
during PRRSV infection. This needs to be investigated in the future.
IRF3/IRF7 are pivotal transcription factors of type I IFNs that participate
in all pathogen recognition receptors (PRRs) signaling pathways
initiating innate immunity. Our data suggested an augmentation of
IRF signals mediated by miR-23 through RLR signaling pathways
(Fig. 6D), implicating that miR-23 might play a role in regulation of
pathogen-host interaction and in innate immunity.
miRNA biogenesis is a highly regulated process in eukaryotic cells.
mir-23 was induced by poly(I:C) (Fig. 7C), a TLR3 ligand, which might
contribute to virus inhibition achieved by poly(I:C) (Zhang et al.,
2013a, 2013b). Multiple strategies have been employed by PRRSV to
counteract TLR and RLR-mediated antiviral activities. As previously
shown, mir-23 was induced by NF-κB (Zhou et al., 2009). And it has
been demonstrated that NF-κB was delayed in activation during
PRRSV infection until 36–48 hpi (Lee and Kleiboeker, 2005). Thus, we
proposed that the delayed induction of NF-κB during PRRSV infection
might inhibit or impair the induction of mir-23 by NF-κB to facilitate
its infection. Interestingly, we found that PRRSV suppressed the poly
(I:C)-induced mir-23 expression (Fig. 7D).
Overall, we demonstrated that over-expression of miR-23, miR-
378, and miR-505 could inhibit PRRSV replication. Additionally,
although clearly deﬁning the physiological role of miR-23 remains
an unﬁnished task, our study provided evidence that miR-23
enhanced type I IFN expression during PRRSV infection, suggesting
that miR-23 could be used as an antiviral therapy against PRRSV
infection.
Materials and methods
Cells and viruses
Marc-145 cells, a monkey kidney cell line highly permissive for
PRRSV infection, were maintained in DMEM supplemented with
10% fetal bovine serum (FBS) and penicillin/streptomycin and were
purchased from the American Type Culture Collection (ATCC no.
CRL-1223). CRL-2843 cells (ATCC no. CRL-2843), which are a
porcine alveolar macrophage cell line, were maintained in RPMI
1640 medium supplemented with 10% FBS and penicillin/strepto-
mycin. Porcine alveolar macrophages (PAMs) were obtained by
lavaging lungs of 8-week-old speciﬁc-pathogen-free (SPF) pigs and
maintained as CRL-2843 cells.
Two type 2 PRRSV strains were used: one was CH-1a (the ﬁrst type
2 PRRSV strain isolated in China; GenBank accession, AY032626),
which was propagated and titrated in Marc-145 cells; and the other
one was JXwn06 (a strain isolated from a pig farm with an atypical
PRRS outbreak in Jiangxi province, China in 2006; GenBank accession,
EF641008.1), which was propagated and titrated in PAMs. Brieﬂy,
PRRS virus was serially diluted 10-fold in complete RPMI 1640 to
infect 5104 PAMs in 96-well plates. PRRSV infectionwas determined
72 h post infection using immunoﬂuorescent staining for PRRSV N
protein. Titrated viruses were then stored at 80 1C until use.
Reagents
Recombinant swine IFN-α was kindly provided by Dr. Wenjun
Liu (Chinese Academy of Sciences, Beijing, China). All miRNA
mimics and inhibitors listed in Table 2 were synthesized from
GenePharma (Shanghai, China). NF-κB inhibitor (BAY11-7082) and
MAPK (p38) inhibitor (SB203580) were purchased from Enzo Life
Sciences. TBK1 inhibitor (BX-795) was purchased from Selleck
Chemicals.
Transfection of miRNA mimics or inhibitors
PAMs or Marc-145 cells were seeded in 12-well plates for 12 h,
and then mimics or inhibitors of miRNAs (60 nM, except for the
dose-dependent experiments) were transfected using Hiperfect
transfection reagents (Qiagen). Twenty-four hours after transfection,
cells were infected with PRRSV. Thirty-six or forty-eight hours later,
the supernatant was collected for virus titration and cells were ﬁxed
for indirect immunoﬂuorescent staining or collected for RNA quanti-
ﬁcation or Western blot analysis.
RNA isolation and quantitative real-time PCR (qRT-PCR)
Cells were harvested using Trizol (Invitrogen) reagent and RNA
was extracted following the manufacturer0s protocol. For miRNAs,
poly(T) adapter RT-PCR was applied as previously described (Shi
et al., 2012). U6 RNAwas set up as an endogenous control. miRNAs
or mRNAs were reverse transcribed with M-MLV Reverse Tran-
scriptase (Takara) and ampliﬁed by using FastSYBR Mixture
(Cwbiotech) on a ViiA™ 7 real-time PCR System (Applied Biosys-
tems). Speciﬁc primers for quantitative analysis of the mRNAs
were designed and listed in Table 3. Primers used to detect
genomic and subgenomic RNAs were used as previously described
(Guo et al., 2013). GAPDH was set up as endogenous controls. All
quantitative real-time PCR experiments were done in triplicate.
Immunoﬂuorescence assay
For detection of PRRSV infection in PAMs, immunoﬂuorescence
assay (IFA) was performed. Cells were ﬁxed in cold methanol-
acetone (1:1) for 10 min at 4 1C, washed with phosphate-buffered
saline (PBS), and then blocked with 10% goat serum in PBS for
30 min. After blocking, cells were incubated with anti-PRRSV
nucleocapsid protein monoclonal antibody SNOW17 (1:10,000;
Rural Technologies), or an isotype control antibody for 60 min at
room temperature. After washing, cells were then incubated with
FITC-conjugated goat anti-mouse IgG antibody (1:2000, Jackson
ImmunoResearch) for 1 h at 37 1C. Cells were then examined using
ﬂuorescence microscopy.
Western blot
For detection of PRRSV structural protein GP5 and host Phos-
pho-IRF3, and IRF3 proteins, cells were lysed with RIPA with a
protease cocktail and proteins were separated on 12% SDS-PAGE
gels and transferred onto polyvinylidene ﬂuoride (PVDF) mem-
branes. Membranes were blocked with 5% milk in PBS with
Tween-20 (PBST 0.025% Tween-20) and probed with Rabbit
anti-GP5 polyclonal antibodies (1:5000, prepared in our lab),
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anti-Phospho-IRF3 polyclonal antibodies (1:1000; #4947, Cell
Signaling), or anti-IRF3 polyclonal antibodies (1:1000; #119041,
Cell Signaling) for 1 h at room temperature. HRP-conjugated anti-
Rabbit secondary antibodies (1:5000, Santa Cruz Biotechnology)
were used to detect primary antibodies, and proteins were
visualized by chemiluminescence. β-actin (1:5000, Sigma) was
set up as a loading control. The intensity of phospho-IRF3 and β-
actin were quantiﬁed using Quantity One software (Bio-Rad) and
the relative gray level of phospho-IRF3 over β-actin was used to
represent the signal strength for phospho-IRF3.
RISC immunoprecipitation (RISC-IP) assay
For conﬁrming the physical interaction between miRNAs and
target RNAs, RISC-IP assay was performed. We adapted the protocol
described previously (Wang et al., 2010b) for immunoprecipitating
Argonaute-2 (Ago2)-mRNA complexes. Brieﬂy, PAMs were seeded in
six-well plates and infected with JXwn06 (MOI¼0.01) for 36 h
following the transfection of miR-23, miR-505, or miR-378 mimics
(60 nM) for 24 h. Then cells were lysed with RIPA with a protease
cocktail. Cell lysates were cleared by centrifugation. Protein-G (40 μl,
Abmart) was incubated with 5 μg of Ago2 antibody (H00027161-
M01, Abnova) or an isotype control IgG (Beyotime). Beads-antibody
complex was blocked with 500 μg/ml yeast RNA (Hualan Chem) for
30 min, followed by 3 washes with PBS and 2 washes with RIPA.
Then cleared lysate was incubated with pre-treated antibody-
protein-G beads overnight at 4 1C. Beads were washed 8 times with
PBS and ﬁnally re-suspended in 250 ml RIPA. Ago2-RNA complexes
were extracted by adding 750 ml of Trizol-LS reagent (Invitrogen)
directly to the beads.
Construction of luciferase reporters and luciferase assays
In order to conﬁrm the target site of miR-23, a 1024 bp
fragment around the predicted miR-23 target site in the PRRSV
strain JXwn06 genome was ampliﬁed and inserted downstream of
the Fireﬂy luciferase gene in the pGL3-control vector (Promega) at
the XbaI site to create the wild type 30UTR vector. miRNA seed site
mutant was made by mutating the underlined 6 nucleotides in the
7-mer-m8 seed sequences (50-cgAGATATTTGGGATAGGGAATGT-
GAg-30 mutated to 50-cgAGATATTTGGGATAGGGATAGGGTg-30)
using a site-directed mutagenesis kit (Stratagene) following the
manufacture0s instructions. For monitoring the activities of tran-
scription factors, NF-κB, ISRE, and IRF3 responding elements were
synthesized and annealed to form double-stand DNA, and then
separately cloned into pGL3-basic promoter region. Another vector
pRL-TK containing the Renilla luciferase was used as a normal-
ization control. All sequences mentioned above were shown in
Table 3.
For luciferase reporter assay, Marc-145 or CRL-2843 cells were
seeded in 12-well plates 12 h before transfection. For cotransfection,
400 ng Fireﬂy luciferase and 20 ng Renilla luciferase reporter plasmids
were transiently transfected into cells with miRNA mimics or inhibi-
tors (60 nM, except for the dose-dependent experiments) using
Lipofectamine 2000 (Invitrogen) for 30 h. In order to test the impact
of miR-23 on RLR pathway, 24 h after the delivery of the mixture of
luciferase reporter vectors and miR-23, transfection of poly(I:C) (1 μg)
into Marc-145 cells was performed with Lipofectamine LTX Reagent
(Invitrogen) to activate the RLR pathway for 12 h. And then, all the
cells were harvested for luciferase activity assay using the Promega
Dual Luciferase kit according to manufacturer0s instructions.
Inhibition of signal transduction pathways
Transfection of miR-23 mimics or NC (60 nM) into PAMs for
24 h was performed prior to the treatment with dimethyl
sulfoxide (DMSO; 1 μM), NF-κB inhibitor BAY11-7082 (1 μM),
p38 mitogen-activated protein kinase (MAPK) inhibitor
SB203580 (5 μM), or TBK1 inhibitor BX-795 (1 μM). After 1 h
incubation with the inhibitors, PAMs were infected with JXwn06
(MOI¼0.01) in the presence of the inhibitors. Forty-eight hours
later, cells were harvested for quantitative real-time PCR analysis.
MTT assay
The MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazo-
lium bromide] assay was used to examine the effect of transfection
with the mimics on cell viability. PAMs in 96-well plates were
transfected with 60 nM miRNAs for 72 h. And then, 20 μl of freshly
made 5 mg/ml MTT solution was added to each well, and the cells
were incubated for another 5 h at 37 1C before the medium was
replaced with 200 μl DMSO to dissolve the crystals. The plates were
further incubated at 37 1C for 5 min to dissolve any air bubbles
before the MTT signal was measured at an absorbance of 550 nm.
TUNEL assay
Detection of cell apoptosis was performed using the TUNEL
assay following the manufacturer0s protocol (Millipore). Brieﬂy,
cells were ﬁxed with 1% paraformaldehyde in PBS for 10 min at
room temperature. After rinsing with PBS, cells were permeabi-
lized using 0.3% Triton X-100 in 0.1% sodium citrate for 4 min.
Then, cells were incubated with the TdT (terminal deoxynucleo-
tidyl transferase) enzyme for 1 h at 37 1C. After stopping the
reaction with stop buffer, cells were washed with PBS and stained
with the anti-digoxigenin-ﬂorescein for 30 min at 37 1C in the
dark. After rinsing with PBS, cells were counterstained with DAPI.
Stained cells were visualized using a ﬂuorescence microscope. Six
visual ﬁelds were randomly selected, and TUNEL-positive and
DAPI positive cells were counted. Results were represented as
percentage of TUNEL-positive cells relative to DAPI-positive cells.
Statistical analysis
Generally, experiments were performed with at least three
independent experiments, with three technical replicates for each
experiment (except for the Western and TUNEL experiments).
Results were analyzed by GraphPad Prism (GraphPad Software,
San Diego, CA) using Student0s t-test or ordinary one-way ANOVA
followed by post hoc Dunnett0s multiple comparison. Differences
were considered to be statistically signiﬁcant if the P value is less
than 0.05. nPo0.05; nnPo0.01; nnnPo0.001.
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